Dr. Hillary S. Maitland, MD

Dr. Maitland practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Maitland's NPI, 1003075839, was assigned on June 6, 2008. Dr. Maitland graduated from Lewis Katz School of Medicine in 2008. Dr. Maitland holds Virginia license 0101252429.

Dr. Maitland's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

Dr. Maitland's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Maitland is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Maitland to 1 more group practice or clinic, named with a free account. Dr. Maitland's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maitland practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Maitland's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Maitland is board certified in hematology by the American Board of Internal Medicine. Dr. Maitland is licensed in Virginia.

Dmand AI lists arterial blot clot /embolism, chronic anemia, deep vein thrombosis (DVT), neutropenia and purpura and thrombocytopenia among the conditions Dr. Maitland treats.

CMS data shows 282 Medicare services from Dr. Maitland across 7 procedure codes in 2024, for 220 Medicare patients. Medicare paid $24,293 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 220 Medicare patients who saw Dr. Maitland in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maitland's median patient age at 56, with 58% women.

In 2024, Dr. Maitland wrote 249 Medicare Part D claims for 66 patients. 13% of them were for generic drugs. CMS names the drug for 201 of them, across 3 drugs with 11 or more claims each, at $750,233 in total drug cost. In 2023, CMS named 208 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Maitland for performance year 2024, reported as part of a group. Dr. Maitland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maitland as offering telehealth.

Dmand AI links 14 papers to Dr. Maitland, published from 2014 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Anticoagulants, Hemorrhage and Venous Thrombosis. Dr. Maitland has published most often in J Vasc Interv Radiol. Dr. Maitland's most frequent co-authors are Stephen H. Caldwell, Gia Ann Deangelis, MD and Ziv J. Haskal, MD.

Dmand AI links Dr. Maitland to 1 clinical trial. Conditions studied include Purpura, Thrombocytopenic, Idiopathic and Purpura, Thrombocytopenic.

CMS Open Payments shows 307 general payments to Dr. Maitland from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $172,807.

Dmand AI lists 1 award for Dr. Maitland, most recently CMS Stage 1 EHR in 2014.

Dr. Maitland graduated from Lewis Katz School of Medicine in 2008. Dr. Maitland is a member of ASH and Hemostasis and Thrombosis Research Society.

Dr. Maitland is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.